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JIVTRODUC7YON- WIfATARENATURAL PRODUCTS?
To a natural-products chemist, the term "natural
products" does not refer to all compounds from
natural sources, as the name might imply, It is
specifically used to refer to compounds known as
secondary metabolites, structurally complex
molecules, often of unknown function, with very
limited biological distribution.
The primary aim of our research group is to isolate
bioactive natural products. A bioactive or
biologically active chemical has an effect on a
living system, which may be good or bad. We
screen these compounds to find useful molecules,
for example, ones that kill fungi or tumour cells.
Such compounds are potential new
pharmaceuticals and can be used as research tools
that help us understand the complex processes that
occur in living organisms. We are also interested in
compounds with novel chemical structures.
Ideally, a new secondary metabolite will have both
interesting activity and a novel structure.
Slime and scum are the types of organisms that we investigate to isolate second
metabolites. Slime refers to terrestrial cyanobacteria and scum to marine bryozoans. A
study these organisms in particular? Tests or screens on many different organisms over
years have shown that they contain many bioactive compounds, which seem to help
organisms in their everyday survival. Cyanobacteria, for example, live in a complex s
containing many other creatures, so need to compete for nutrients and space. It
advantageous for them to produce compounds that may inhibit the growth of compet
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bacteria or fungi, leaving more resources for themselves. Marine bryozoans could also use
chemicals to help them in their lives: they are primitive animals that are anchored to the
seabed and are therefore, vulnerable to predation, overgrowth or infection. With no immune
system, the theory is that bryozoans produce chemicals to help in their defence.
GENERAL APPROACH 7t RI'SEARCH
How do we isolate bioactive compounds? The same process applies for both cyanobacteria
and bryozoans. We extract the organism by homogenising it mashing it up in a blender with
a suitable solvent. The extract is then filtered and the excess solvent is removed to leave a
crude extract containing many different compounds, including the one that we are trying to
isolate. Murphys law means that this substance is often present in trace amounts only, so
getting it out is a challenge. Fractionation techniques and various forms of chromatography
are used to separate and isolate the compounds of interest.
Bioassays are tests that we use to monitor the isolation process and to determine in which
fractions biologically active compounds are located. The assays that we use routinely screen
for anti-tumour, anti-viral and anti-microbial activity, but we have access to some more
specialised assays if required. Active fractions are combined and the process of fractionation
and assay is repeated until, hopefully, we isolate a pure, active compound.
Once an interesting compound is isolated, the next step is to determine its structure. The most
useful structural determination technique for the natural-products chemist is nuclear magnetic
resonance NMR spectroscopy. This technique allows us to exploit the magnetic properties of
certain atomic nuclei to determine molecular structure. Not all elements are observable by
NMR spectroscopy but, luckily for the organic chemist, hydrogen and carbon are, so we can
usually obtain a lot of structural information about organic compounds. Other techniques,
such as mass spectrometry and X-ray crystallography, are also used.
SLLfE
What are cyanobacteria? They are neither plants nor animals. They look just like slime and
are similar to bacteria in that they are usually unicellular and lack a distinct nucleus.
However, unlike most bacteria, they contain chlorophyll and, like plants, carry out
photosynthesis. A commonly used name for cyanobacteria is blue-green algae, even though
they are not really algae at all and only some of them have the distinctive blue-green cyan
colouration.
Why are we interested in cyanobacteria? They have existed for four billion years and are well
adapted to their environment. They occur in a wide range of habitats such as fresh water, soil
and salt water, from the cold of Antarctica to the heat of volcanic areas, so are very versatile
organisms.
It is not feasible to collect sufficient quantities of cyanobacteria in the field for research into the
secondary metabolites that they contain. Even if there is an `algal bloom' in a water body, it
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will not be a clean, homogeneous culture. The solution to this problem is to collect a small
sample of material, isolate an individual species and culture it in the laboratory under
controlled conditions to produce enough organisms to work with, The cyanobacteria are
cultured on a medium of inorganic mineral salts and provided with constant light and a low
level of carbon dioxide as a carbon source, They are initially cultured in conical flasks, then
transferred to larger vessels. Cyanobacteria have proven to be an excellent source of novel,
biologically active compounds as the following examples illustrate.
Many different classes of compounds have been isolated from cyanobacteria, but the types of
compounds most commonly isolated are cyclic peptides. Some of these, such as the
tnicrocystins," have proven to be a problem in lakes and rivers, causing poisoning and even
death of stock which drink there. These compounds are hepatotoxins, damaging the liver of
affected animals.
CO2H Ma 0
Ma Ms
Ma 0 CO2HO
Microcystin-LA, one of the family of microcystins
isolated from various species of cyanobacteria.
Other cyclic peptides isolated from cyanobacteria have beneficial properties. Westiellanzide is
a cyclic hexapeptide containing six amino acids that displays anti-tumour activity.3 It was
isolated from a terrestrial cyanobacteriuin from Hawaii. The same compound has been found
in a marine organism called a tunicate, but in this case it is thought to be produced by the
prokaryotic symbionts located in the tun.icate cells.4
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Tolyporphin A was isolated from a cyanobacterium from Pohnpei in Micronesia.5 It displays
multi-drug resistance MDR reversing activity. Patients on prolonged chemotherapy become
resistant to a wide range of therapeutic drugs. The cancer cells may actively pump drugs out,
causing the resistance. Tolyporphin A reverses that resistance by binding to the cellular pump
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and inhibiting it, so that drugs can get into cancer cells to kill them.6 We have subsequently
isolated Tolyporphins B - K/ and conducted various studies on them, such as mode of action
and metal binding studies. Toyporphin A itself makes tumours more sensitive to a type of
cancer treatment called photodynaniic therapy and is currently under further investigation for
use for this purpose?
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Tolypodiol was isolated from the same cyanobacterium as tolyporphin A.'° It is also a novel
compound with excellent anti-inflammatory activity and has gone on to further investigation
in the United States to assess its potential as an anti-arthritis compound.
Tolypodiol
SCUM
Bryozoaris or `moss animals' are colonies of tiny filter-feeding individuals or zooids that are
common fouling organisms on such things as ships, jetty piles and nets, hence the use of the
term scum to describe them. Bryozoans are somewhat understudied biochemically, but work
to date has indicated that they are art excellent source of novel, biologically active compounds.
The best example of this is the bryozoan species Bugula neritina, which is the source of a
compound called bryostatin 1. This is currently in advanced clinical trials for a number of
cancers, including melanoma and leukaemia, and may well come on line as an anti-cancer
drug.2
As stated above, bryozoans are understudied from a chemical point of view. There are several
reasons why, including accessibility problems. Many bryozoans live below the depths that
can be reached by divers and require the use of a dredge or submersible for collection. A
submersible is very expensive and a dredge is very non-selective.
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Obtaining sufficient quantities for research is another problem. Although some species are
soft and feathery, most are instead heavily calcified. Therefore, very large quantities of
material have to be collected to obtain enough to work with. Still other species grow in thin,
encrusting forms that are also difficult to collect.
Accurate taxonomy is very important. You can get quite different colouration between
different specimens of the same species, or you can have several samples that look identical
but are in fact different species, which can only be distinguished by examination under the
microscope. We are very fortunate to have expert assistance in bryozoan taxonomy from
scientists at NIWA Oceanographic in Wellington.
Despite the problems associated with bryozoan research, New Zealand is quite a good place
in which to study them. Obviously, we are surrounded by water and have a long coastline
and we also have a very good species diversity of bryozoans with a high proportion of
endemic species.
Our research strategy is to collect as wide a species diversity as possible, extract them and
screen for biological activity,
Investigation of a New Zealand bryozoan, Cribricellina cribraria resulted in the isolation of a
series of fl'.carboline alkaloids of which two novel ones are shown below. These exhibit a
range of biological activities including anti-tumour and anti-fungal activities.13 Other bryozoans
in the same family contain these alkaloids, but composition and quantities vary quite widely.'4
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Novel alkaloids isolated from Cribricellina cribraria
Some recent examples of our work include an investigation of the bryozoan Ama thia wilsoni,
which contains a series of alkaloids, the amathaspiramides.'5 These compounds are
structurally very similar to a series of compounds called the amathamides, which were
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isolated from Australian collections of Amathia wilsoni." Interestingly, although both
Australian and New Zealand organisms have been identified as the same species
taxonomically, the Australian samples only seem to produce amathamides, while New
Zealand colonies only produce the amathaspiramides.
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The species Euthyroides episcopalis contains the euthyroideones, which represent examples of a
new ring structure.'9 These compounds contain an unusual combination of functional groups
and are very interesting from a structural point of view.
F
Amathamida F: R Br
A B C
Euthyroidenes A-C
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The bryozoan Watersipora subtorquata contains some compounds described by their basic ring
structure as anthraquinones. This ring structure was already known, but our group was able
to carry out research into their biological activity and determine how altering various
functional groups in the structures affected the biological activity.20
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Anthraquinones isolated from Watersipora subtorquata
This ongoing research demonstrates the utility of natural products research as a source of
compounds that may be useful as pharmaceuticals and/or are of structural interest to a
chemist. As we search for potential new pharmaceutical compounds in both terrestrial
cyanobacteria and marine bryozoans, we are constantly amazed at nature's ability for organic
synthesis.
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